National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

HARDBACK
price:$49.95
add to cart

Rights & Permissions

topleft topright

Kidney Failure and the Federal Government (1991)
Institute of Medicine (IOM)

Citation Manager

. "Part V: Data and Research, Data Systems." Kidney Failure and the Federal Government. Washington, DC: The National Academies Press, 1991.

Please select a format:

BibTeX EndNote RefMan


Page
327
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


Kidney Failure and the Federal Government

REFERENCES

DHHS (U.S. Department of Health and Human Services). 1987. Report to Congress on National End-Stage Renal Disease Patient Registry Required by P.L. 99-509. Washington, D.C.: April.


HCFA (Health Care Financing Administration). 1979. End-Stage Renal Disease Program: Annual Report to Congress, 1979; P.L. 95-292, 1881(g). Washington, D.C.

HCFA. 1980. End-Stage Renal Disease Program: Second Annual Report to Congress, FY 1980. Washington, D.C.

HCFA. 1982. 1981 End-Stage Renal Disease Annual Report to Congress. Washington, D.C.


UNOS (United Network for Organ Sharing). 1990. Annual Report on the Scientific Registry for Organ Transplantation and the Organ Procurement and Transplantation Network, 1988 & 1989. U.S. Department of Health and Human Services. Washington, D.C.

USRDS (U.S. Renal Data System). 1989. Annual Report. National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, August.

USRDS. 1990a. Annual Report. National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, August.

USRDS. 1990b. Gold Notes. Washington, D.C. March 30.

Page
327
Front Matter (R1-R14)
Part I: Overview, Summary (1-22)
Introduction (23-36)
Part II: Patients and Providers, Perspectives of ESRD Patients (37-50)
Ethical Issues (51-61)
The Patient Population (62-84)
The ESRD Patient Population: Special Groups (85-109)
Structure of the Provider Community (110-132)
Part III: Access, Access Problems of ESRD Patients (133-166)
Access to Kidney Transplantation (167-188)
Part IV: Reimbursement and Quality, Medicare ESRD Payment Policy (189-211)
Reimbusement Effects on Quality (212-235)
Outpatient Dialysis Reimbursement Issues (236-273)
Quality Assessment and Assurance (274-312)
Part V: Data and Research, Data Systems (313-327)
Research Needs (328-334)
Appendix A: Glossary (335-346)
Appendix B: Acronyms and Initialisms (347-350)
Appendix C: Commissioned Papers and Contractor Reports (351-352)
Appendix D: Survival Analysis Methods for the End-Stage Renal Disease (ESRD) Program of Medicare (353-400)
Appendix E: Institute of Medicine ESRD Study Committee Public Hearing, May 5, 1989, Chicago, Illinois (401-402)
Appendix F: Institute of Medicine ESRD Study Committee Public Hearing on (403-404)
Appendix G: Institute of Medicine ESRD Study Committee Workshop on ESRD Staffing, November 3, 1989, Washington, D.C. (405-405)
Appendix H: Institute of Medicine ESRD Study Committee Workshop on Kidney Transplantation, December 13, 1989, Washington, D.C. (406-407)
Appendix I: Institute of Medicine ESRD Study Committee Workshop on Black and Other Nonwhite ESRD Patients, May 15, 1990, Washington, D.C. (408-408)
Appendix J: Institute of Medicine ESRD Study Committee ESRD Patient Focus-Group Participants (409-410)
Index (411-426)